|
Aug-17-26 07:01PM
|
INVO Fertility Inc (IVF) (Q2 2026) Earnings Call Highlights: Revenue Surges 17% as Clinic-Level ...
|
link
|
(GuruFocus.com)
|
|
Aug-17-26 10:58AM
|
INVO Fertility Q2 Revenue Rises 17% as Clinic-Level Profitability Improves
|
link
|
(InvestorsHub)
|
|
Aug-17-26 08:30AM
|
INVO Fertility Reports Second Quarter 2026 Results Highlighting Revenue Growth and Clinic Platform Profitability
|
link
|
(GlobeNewswire)
|
|
Jun-25-26 09:33PM
|
SHPH, ILLR, IVF: Why These Stocks Posted Double-Digit Gains After-Hours Today
|
link
|
(Stocktwits)
|
|
Jun-22-26 09:00AM
|
INVO Fertility Reports First Quarter 2026 Results Reflecting Strong Revenue Growth, Expanded Fertility Clinic Platform, and Improved Capital Structure
|
link
|
(GlobeNewswire)
|
|
Jun-02-26 04:50PM
|
INVO Fertility Receives Nasdaq Notification Regarding Late Filing of Quarterly Report on Form 10-Q
|
link
|
(GlobeNewswire)
|
|
Jun-02-26 08:30AM
|
INVO Fertility Announces Fiscal Year 2025 Financial Results
|
link
|
(GlobeNewswire)
|
|
Apr-29-26 04:05PM
|
INVO Fertility Receives Nasdaq Notification Regarding Late Filing of Annual Report on Form 10-K
|
link
|
(GlobeNewswire)
|
|
Mar-25-26 08:30AM
|
INVO Fertility Announces a 1:5 Reverse Stock Split Effective Pre-Market Opening on March 27, 2026
|
link
|
(GlobeNewswire)
|
|
Mar-05-26 09:00AM
|
INVO Fertility Announces Availability of Advanced Incubation Technology at its Wisconsin Clinic
|
link
|
(GlobeNewswire)
|
|
Mar-03-26 08:45AM
|
INVO Fertility's Wisconsin Clinic Joins Progyny Network
|
link
|
(GlobeNewswire)
|
|
Feb-19-26 08:30AM
|
INVO Fertility Closes Acquisition of Indiana-Based Fertility Clinic "Family Beginnings"
|
link
|
(GlobeNewswire)
|
|
Feb-11-26 08:30AM
|
INVO Fertility Announces Patent Issuance for Modified INVOcell Device
|
link
|
(GlobeNewswire)
|
|
Feb-04-26 09:00AM
|
INVO Fertility Issues Shareholder Letter Highlighting Strengthened Fundamental Position and Strategic Outlook for Growth
|
link
|
(GlobeNewswire)
|
|
Jan-29-26 08:30AM
|
INVO Fertility Enters into $7.5 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules
|
link
|
(GlobeNewswire)
|
|
Jan-24-26 09:02AM
|
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
|
link
|
(Benzinga)
|
|
Jan-20-26 09:48PM
|
Why INVO Fertility (IVF) Stock Is Trending Overnight
|
link
|
(Benzinga)
|
|
Jan-20-26 04:34PM
|
This Little-Known Fertility Stock Is Up 215% in the Past 5 Days. Should You Chase the Mysterious Penny Stock Rally Here?
|
link
|
(Barchart)
|
|
Jan-13-26 04:15PM
|
INVO Fertility to Participate in the Lytham Partners 2026 Investor Healthcare Summit on January 15, 2026
|
link
|
(GlobeNewswire)
|
|
Dec-30-25 04:05PM
|
INVO Fertility Aligns Executive Leadership Structure to Support Growth Strategy
|
link
|
(GlobeNewswire)
|
|
Dec-17-25 09:00AM
|
INVO Fertility Signs Definitive Purchase Agreement to Acquire Indiana-Based Fertility Clinic "Family Beginnings"
|
link
|
(GlobeNewswire)
|
|
Dec-02-25 09:25AM
|
INVO Fertility Announces Pricing of $4.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules
|
link
|
(GlobeNewswire)
|
|
Nov-28-25 01:05PM
|
INVO Fertility Announces Intent to Acquire Indiana-Based Fertility Clinic "Family Beginnings"
|
link
|
(GlobeNewswire)
|
|
Nov-25-25 09:00AM
|
INVO Fertility Announces a 1:8 Reverse Stock Split Effective Pre-Market Opening on November 28, 2025
|
link
|
(GlobeNewswire)
|
|
Nov-17-25 08:30AM
|
INVO Fertility Announces Third Quarter 2025 Financial Results
|
link
|
(GlobeNewswire)
|
|
Oct-27-25 08:30AM
|
INVO Fertility Partners with Heidi Health to Bring AI-Powered Tools to INVO's Wisconsin Fertility Institute
|
link
|
(GlobeNewswire)
|
|
Sep-29-25 05:30PM
|
INVO Fertility to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025
|
link
|
(GlobeNewswire)
|
|
Aug-14-25 05:34PM
|
INVO Fertility Announces Second Quarter 2025 Financial Results
|
link
|
(GlobeNewswire)
|
|
Jul-22-25 10:30AM
|
BC-Most Active Stocks
|
link
|
(Associated Press Finance)
|
|
Jul-17-25 08:00AM
|
INVO Fertility Announces a 1:3 Reverse Stock Split Effective Pre-Market Opening on July 21, 2025
|
link
|
(GlobeNewswire)
|
|
Jul-09-25 09:00AM
|
INVO Fertility Enhances INVOcell Technology with Expanded Awareness, Training, and Improved Pricing
|
link
|
(GlobeNewswire)
|
|
Jul-09-25 08:42AM
|
INVO Underwriting, LLC Taps Input 1 to Power Seamless Digital Payments for Agents and Policyholders
|
link
|
(PR Newswire)
|
|
Jun-30-25 09:00AM
|
INVO Fertility Adds Platelet-Rich Plasma Therapy Capabilities at Wisconsin Fertility Institute
|
link
|
(GlobeNewswire)
|
|
Jun-25-25 09:00AM
|
INVO Fertility Receives Notice of Allowance for Modified INVOcell Device Patent
|
link
|
(GlobeNewswire)
|
|
Jun-20-25 09:00AM
|
INVO Fertility Reminds Shareholders to Cast Their Vote for Upcoming Annual Meeting of Shareholders to be held on Wednesday, June 25, 2025 at 12:00 p.m. Eastern Time
|
link
|
(GlobeNewswire)
|
|
Jun-18-25 09:00AM
|
INVO Fertility Expands Telehealth Capabilities at Its Wisconsin Fertility Institute
|
link
|
(GlobeNewswire)
|
|
Jun-16-25 09:00AM
|
INVO Fertility's Wisconsin Clinic Recognized on Newsweek's List of America's Best Fertility Clinics for 2025
|
link
|
(GlobeNewswire)
|
|
May-27-25 05:00PM
|
INVO Fertility to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
|
link
|
(GlobeNewswire)
|
|
May-20-25 04:05PM
|
INVO Fertility Announces First Quarter 2025 Financial Results
|
link
|
(GlobeNewswire)
|
|
Apr-30-25 09:00AM
|
INVO Fertility Announces 2024 Financial Results with 116% Annual Revenue Growth and Further Improvements in Adjusted EBITDA
|
link
|
(GlobeNewswire)
|
|
Apr-24-25 09:00AM
|
INVO Fertility Confirms New Nasdaq Trading Symbol of IVF
|
link
|
(GlobeNewswire)
|
|
Apr-14-25 07:30PM
|
NAYA Biosciences Announces Strategic Decision to Separate Fertility and Oncology Businesses into Distinct Operations Company Renamed INVO Fertility, Inc.
|
link
|
(GlobeNewswire)
|
|
Mar-13-25 04:30PM
|
NAYA Announces a 1:12 Reverse Stock Split Effective Pre-Market Opening on March 18, 2025
|
link
|
(GlobeNewswire)
|
|
Feb-25-25 08:00AM
|
NAYA Biosciences Supports Recent Executive Order Aimed at Improving Access to Fertility Treatment
|
link
|
(GlobeNewswire)
|
|
Feb-19-25 09:15AM
|
NAYA Biosciences Announces Nomination of New Board Members
|
link
|
(GlobeNewswire)
|
|
Jan-13-25 09:15AM
|
NAYA Biosciences Announces Pricing of $9.5 Million Public Offering
|
link
|
(GlobeNewswire)
|
|
Jan-06-25 08:30AM
|
NAYA Biosciences Announces Development of NY-500, a Novel AI-Optimized PD-1 x VEGF Bifunctional Antibody
|
link
|
(GlobeNewswire)
|
|
Oct-31-24 09:00AM
|
NAYA Biosciences to Present Translational Insights to Support Phase I/IIa Clinical Trials for its GPC3-Targeting NK Engager Bispecific Antibody at the 2024 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
|
link
|
(GlobeNewswire)
|
|
Oct-24-24 09:00AM
|
NAYA Biosciences Announces Initiation of Phase 1/2a Clinical Trial for its GPC3-targeted NK Engager Bispecific Antibody in Patients with Hepatocellular Carcinoma
|
link
|
(GlobeNewswire)
|
|
Oct-21-24 09:00AM
|
INVO Bioscience Confirms Corporate Name Change and New Trading Symbol in Connection with Its Recent Merger with NAYA Biosciences
|
link
|
(GlobeNewswire)
|
|
Oct-14-24 09:18AM
|
INVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences (NASDAQ: NAYA)
|
link
|
(GlobeNewswire)
|
|
Aug-14-24 09:00AM
|
INVO Reports Record Second Quarter 2024 Financial Results with 481% Revenue Growth and a $1.1 Million Improvement to Adjusted EBITDA
|
link
|
(GlobeNewswire)
|
|
May-15-24 09:53PM
|
INVO Stock Earnings: INVO Bioscience Reported Results for Q1 2024
|
link
|
(InvestorPlace)
|
|
May-15-24 04:15PM
|
INVO Reports Record First Quarter 2024 Financial Results
|
link
|
(GlobeNewswire)
|
|
May-14-24 07:34AM
|
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
|
link
|
(InvestorPlace)
|
|
Apr-17-24 08:16AM
|
Why Is Invo Bioscience (INVO) Stock Up 85% Today?
|
link
|
(InvestorPlace)
|
|
Apr-16-24 09:53PM
|
INVO Stock Earnings: INVO Bioscience Reported Results for Q4 2023
|
link
|
(InvestorPlace)
|
|
Apr-16-24 04:59PM
|
INVO Reports Fourth Quarter and Full Year 2023 Financial Results
|
link
|
(GlobeNewswire)
|
|
Jan-23-24 08:00AM
|
NAYA Biosciences To Acquire Clinical Stage Gene Therapy Program for Leber's Hereditary Optic Neuropathy (LHON)
|
link
|
(GlobeNewswire)
|
|
Jan-17-24 08:00AM
|
INVO Bioscience Files S-4 Registration and Preliminary Joint Proxy Statements in Connection with Merger with NAYA Biosciences, NAYA Announces New Board Directors
|
link
|
(GlobeNewswire)
|
|
Dec-11-23 08:00AM
|
NAYA Biosciences Announces Publication of New Data for its CD38-targeted Flex-NK Bispecific Antibody in the American Society of Hematology's Blood Journal
|
link
|
(PR Newswire)
|
|
Dec-06-23 09:00AM
|
NAYA Biosciences and ONK Therapeutics Announce Research Partnership to Advance Combination Therapy of FLEX-NK Bispecific Antibodies and Optimally Engineered Off-the-Shelf Natural Killer Cell Therapies
|
link
|
(PR Newswire)
|
|
Nov-28-23 09:00AM
|
INVO Bioscience Regains Compliance with Nasdaq Minimum Stockholders' Equity Requirement
|
link
|
(PR Newswire)
|
|
Nov-13-23 04:01PM
|
INVO Reports Record Third Quarter 2023 Financial Results
|
link
|
(PR Newswire)
|
|
Nov-13-23 08:15AM
|
BestGrowthStocks.Com Issues Comprehensive Analysis Regarding INVO Biosciences Merger
|
link
|
(News Direct)
|
|
Nov-10-23 09:00AM
|
NAYA Biosciences and INVO Bioscience Announce Appointment of Dr. Peter Kash, Ed.D., MBA as Vice Chairman Following Closing of Their Pending Merger
|
link
|
(PR Newswire)
|
|
Nov-09-23 04:40PM
|
INVO Bioscience Announces Commencement of Waiver Solicitation From Holders of the Company's Common Stock Purchase Warrants
|
link
|
(PR Newswire)
|
|
Oct-27-23 09:00AM
|
Free Registration Is Now Open For Tribe Public's CEO and Q&A Presentation Webinar Event "Accelerating Biotech Value Creation" Featuring NAYA Biosciences CEO Dr. Daniel Teper On Tuesday, October 31, 2023
|
link
|
(PR Newswire)
|
|
Oct-24-23 10:08AM
|
Moore Kuehn Encourages INVO, ESMT, HES, and TGH Investors to Contact Law Firm
|
link
|
(GlobeNewswire)
|
|
Oct-24-23 08:45AM
|
Why the Relapsed/Refractory Acute Myeloid Leukemia Market is Expected to Witness Revolutionary Developments
|
link
|
(PR Newswire)
|
|
Oct-23-23 01:40PM
|
Why Is INVO Bioscience (INVO) Stock Up 325% Today?
|
link
|
(InvestorPlace)
|
|
Oct-23-23 07:30AM
|
INVO Bioscience and NAYA Biosciences Announce Definitive Merger Agreement To Establish Expanded Publicly Traded Life Science Company
|
link
|
(PR Newswire)
|
|
Oct-11-23 09:00AM
|
INVO to Participate in the Lytham Partners Fall 2023 Investor Conference
|
link
|
(PR Newswire)
|
|
Sep-29-23 04:05PM
|
INVO BIOSCIENCE ANNOUNCES ADJOURNMENT OF SPECIAL MEETING OF SHAREHOLDERS
|
link
|
(PR Newswire)
|
|
Sep-28-23 12:30PM
|
INVO Reminds Shareholders to Cast Their Vote for Upcoming Special Meeting of Shareholders to be held on Friday, September 29, 2023 at 12:00 p.m. ET
|
link
|
(PR Newswire)
|
|
Aug-14-23 04:05PM
|
INVO Reports Second Quarter 2023 Financial Results
|
link
|
(PR Newswire)
|
|
Aug-11-23 08:00AM
|
INVO Closes Acquisition of Wisconsin Fertility Institute
|
link
|
(PR Newswire)
|
|
Aug-09-23 04:15PM
|
INVO to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023
|
link
|
(PR Newswire)
|
|
Aug-08-23 01:55PM
|
INVO Bioscience Announces Closing of $4.5 Million Public Offering
|
link
|
(PR Newswire)
|
|
Aug-04-23 09:00AM
|
INVO Bioscience Announces Pricing of $4.5 Million Public Offering
|
link
|
(PR Newswire)
|
|
Aug-03-23 08:00AM
|
INVO Sets Revised Closing Date of Wisconsin Fertility Institute Acquisition and Announces Key Operational Trends to Drive Shareholder Value
|
link
|
(PR Newswire)
|
|
Jul-27-23 09:26AM
|
INVO Announces a 1:20 Reverse Stock Split Effective Pre-Market Opening on July 28, 2023
|
link
|
(PR Newswire)
|
|
Jun-27-23 09:00AM
|
INVO Receives 510(k) FDA Clearance for Expanded Use of the INVOcell Device
|
link
|
(PR Newswire)
|
|
May-15-23 04:05PM
|
INVO Reports First Quarter 2023 Financial Results
|
link
|
(PR Newswire)
|
|
May-08-23 04:15PM
|
INVO Bioscience to Report First Quarter 2023 Financial Results on Monday, May 15, 2023
|
link
|
(PR Newswire)
|
|
Apr-17-23 04:05PM
|
INVO Reports Fourth Quarter and Full Year 2022 Financial Results
|
link
|
(PR Newswire)
|
|
Apr-11-23 05:30PM
|
INVO Bioscience to Report Fourth Quarter and Fiscal Year 2022 Financial Results on Monday, April 17, 2023
|
link
|
(PR Newswire)
|
|
Apr-05-23 09:00AM
|
INVO Congratulates Wisconsin Fertility Institute on Being Named One of America's Best Fertility Clinics by Newsweek
|
link
|
(PR Newswire)
|
|
Mar-30-23 05:25PM
|
INVO Provides Preliminary Update on FY2022 Financial Results
|
link
|
(PR Newswire)
|
|
Mar-27-23 05:06PM
|
INVO Bioscience Announces Closing of $3.0 Million Registered Direct Offering
|
link
|
(PR Newswire)
|
|
Mar-24-23 08:00AM
|
INVO Bioscience Announces Pricing of $3.0 Million Registered Direct Offering Priced At-The-Market
|
link
|
(PR Newswire)
|
|
Mar-20-23 09:00AM
|
INVO Signs Binding Agreements to Acquire Wisconsin Fertility Institute
|
link
|
(PR Newswire)
|
|
Jan-05-23 09:00AM
|
INVO Bioscience Enters Distribution Agreement for Taiwan
|
link
|
(PR Newswire)
|
|
Jan-03-23 09:00AM
|
INVO Bioscience Engages Nationally Recognized Physician for New Tampa-based INVO Center
|
link
|
(PR Newswire)
|
|
Nov-30-22 09:30AM
|
First Baby Born in Malaysia Utilizing Innovative INVOcell Assisted Reproductive Technology
|
link
|
(PR Newswire)
|
|
Nov-14-22 04:05PM
|
INVO Bioscience Reports Third Quarter 2022 Financial Results
|
link
|
(PR Newswire)
|
|
Nov-10-22 04:15PM
|
INVO Bioscience to Report Third Quarter 2022 Financial Results on Monday, November 14, 2022
|
link
|
(PR Newswire)
|
|
Nov-01-22 09:00AM
|
INVO Bioscience Highlights INVOcell Progress From the 2022 American Society for Reproductive Medicine (ASRM) Congress & Expo
|
link
|
(PR Newswire)
|
|
Oct-21-22 09:00AM
|
INVOcell Review Published in Current Opinion in Obstetrics and Gynecology
|
link
|
(PR Newswire)
|
|
Oct-17-22 09:00AM
|
INVO Bioscience to Exhibit at the 2022 American Society for Reproductive Medicine (ASRM) Congress & Expo
|
link
|
(PR Newswire)
|